Suppr超能文献

周年综述:抗甲状腺药物治疗:70 年后。

ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years later.

机构信息

National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Division of Endocrinology, Diabetes, and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Eur J Endocrinol. 2018 Oct 12;179(5):R261-R274. doi: 10.1530/EJE-18-0678.

Abstract

The thionamide antithyroid drugs were discovered in large part following serendipitous observations by a number of investigators in the 1940s who found that sulfhydryl-containing compounds were goitrogenic in animals. This prompted Prof. Edwin B Astwood to pioneer the use of these compounds to treat hyperthyroidism in the early 1940s and to develop the more potent and less toxic drugs that are used today. Despite their simple molecular structure and ease of use, many uncertainties remain, including their mechanism(s) of action, clinical role, optimal use in pregnancy and the prediction and prevention of rare but potentially life-threatening adverse reactions. In this review, we summarize the history of the development of these drugs and outline their current role in the clinical management of patients with hyperthyroidism.

摘要

硫脲类抗甲状腺药物在很大程度上是由于 20 世纪 40 年代许多研究人员的偶然观察而发现的,他们发现含巯基的化合物在动物中具有致甲状腺肿作用。这促使 Edwin B Astwood 教授在 20 世纪 40 年代早期率先使用这些化合物治疗甲状腺功能亢进,并开发出今天使用的更有效和毒性更小的药物。尽管这些药物具有简单的分子结构和易用性,但仍存在许多不确定性,包括其作用机制、临床作用、在妊娠中的最佳应用以及预测和预防罕见但可能危及生命的不良反应。在这篇综述中,我们总结了这些药物的发展历史,并概述了它们在甲状腺功能亢进症患者临床管理中的当前作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验